Get 20% Free Customization In This Report

Buy this report from - $3456

Eye Care Surgical Market by Application (Cataract Surgery, Glaucoma Surgery, Refractive Surgery, Corneal Surgery, Vitreo-Retinal Surgery, and Oculoplastic Surgery) and End User (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics, and Eye Research Institutes) - Global Opportunities and Industry Forecasts, 2017-2023

Healthcare	LI_183832	Pages: NA	May 2018 \| 563 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Eye care involves examining of the eyes to detect abnormalities or defects and provide medical diagnosis & management of eye disease. An eye is a delicate organ, which requires continuous care before, during, and after a surgical procedure. Surgical devices are used to treat various eye-related diseases such as cataract, glaucoma, and refractive error, which pose as a health burden globally.

The major factors that contribute to the growth of the eye care surgical market include increasing prevalence of eye-related diseases such as glaucoma, cataract, diabetic retinopathy, refractive errors, increasing geriatric population, echnological advancements, high demand for diagnostic procedures, and minimally invasive procedures. However, factors such as high costs of devices and dearth of skilled professionals with expertise in ophthalmic surgery can restrain the growth of the market. The development of advanced products such as advances in laser technology and increasing healthcare infrastructure in untapped markets provide numerous opportunities for the market growth during the forecast period.

The eye care surgical market is segmented on the basis of application, end user, and region. According to application, the market is divided into cataract surgery, glaucoma surgery, refractive surgery, corneal surgery, vitreo-retinal surgery, oculoplastic surgery, and others, which include eye removal and eye muscle surgery. On the basis of end user, the market is segmented hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Bausch & Lomb Incorporated, Novartis AG, Abbott Laboartories, LUMENIS, Topcon Corporation, Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Essilor, A.R.C. Laser GmbH, and Ophthalmic Instruments Inc.

Key Benefits

The study provides an in-depth analysis of the global eye care surgical market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global eye care surgical market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global eye care surgical market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global eye care surgical market.

Eye Care Surgical Market Key Segments:

By Application

Cataract Surgery
Glaucoma Surgery
Refractive Surgery
Corneal Surgery
Vitreo-Retinal Surgery
Oculoplastic Surgery
Others

By End User

Hospitals
Ambulatory Surgical Centers
Ophthalmology Clinics
Eye Research Institutes

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 EYE CARE SURGICAL MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CATARACT SURGERY

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. GLAUCOMA SURGERY

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. REFRACTIVE SURGERY

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. CORNEAL SURGERY

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. VITREO-RETINAL SURGERY

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. OCULOPLASTIC SURGERY

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

4.8. OTHERS

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

Chapter: 5 EYE CARE SURGICAL MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Key market trends

5.3. AMBULATORY SURGICAL CENTERS

5.3.1. Key market trends

5.4. OPHTHALMOLOGY CLINICS

5.4.1. Key market trends

5.5. EYE RESEARCH INSTITUTES

5.5.1. Key market trends

Chapter: 6 EYE CARE SURGICAL MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America eye care surgical market by application
6.2.5. North America eye care surgical market by end user

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe eye care surgical market by application
6.3.5. Europe eye care surgical market by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific eye care surgical market by application
6.4.5. Asia-Pacific eye care surgical market by end user

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA eye care surgical market by application
6.5.5. LAMEA eye care surgical market by end user

Chapter: 7 COMPANY PROFILES

7.1. BAUSCH & LOMB INCORPORATED

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. NOVARTIS AG

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. ABBOTT LABOARTORIES

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. LUMENIS

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. TOPCON CORPORATION

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. CARL ZEISS MEDITEC AG

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. VALEANT PHARMACEUTICALS INTERNATIONAL INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. ESSILOR

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. A.R.C. LASER GMBH

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. OPHTHALMIC INSTRUMENTS INC.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.